Oily to Imperfection-Prone Skin
Effaclar (+) Anti-Blackhead Moisturiser helps reduce the visibility of blackheads, and improves skin texture and shine. From the very first application of Effaclar (+) Anti-Blackhead Moisturiser, skin feels detoxified and purified for a fresh skin feeling that lasts all day long. After just 1 month, skin looks transformed: skin texture is smoother, pores are unclogged and shine is reduced.
Effaclar (+) Anti-Blackhead Moisturiser provides moisture and comfort for the whole day - following use, skin looks mattified and imperfections reduced. Designed for combination to oily skin, and suitable for those with sensitive skin, and imperfection and blackhead prone skin.
Formulated with effective ingredients, including:
Carnosine: protects skin by reducing oxidation.
Airlicium™: A molecule able to absorb 150 times its volume in sebum to mattify the skin. LHA and Salicylic Acid micro-exfoliates the skins surface and unclogs pores.
Please be aware that ingredient lists for the products of our brand are updated regularly. Please refer to the ingredient list on your product package for the most up to date list of ingredients to ensure it is suitable to your personal use.
AQUA / WATER • PROPYLENE GLYCOL • OCTYLDODECANOL • DIMETHICONE • PEG-100 STEARATE • GLYCERYL STEARATE • SALICYLIC ACID • AMMONIUM POLYACRYLDIMETHYLTAURAMIDE / AMMONIUM POLYACRYLOYLDIMETHYL TAURATE • ZINC PCA • SARCOSINE • SODIUM HYDROXIDE • SILICA • SILICA SILYLATE • PERLITE • CARNOSINE • DISODIUM EDTA • CAPRYLOYL SALICYLIC ACID • XANTHAN GUM • PENTYLENE GLYCOL • ACRYLATES COPOLYMER • CETYL ALCOHOL • BUTYLENE GLYCOL • TOCOPHEROL • PARFUM / FRAGRANCE
Warming the product in your hands before application will bring it to body temperature and will promote better assimilation of the active ingredients.
The 3-step EFFACLAR routine – cleanse, correct, protect – shows proven effectiveness on subjects with acne-prone skin living in polluted environments.*
*Quantitative study, Beijing/Shanghai, 2014, Total sample: n=600 ²DIM Sell-in YTD Sept 2015 ³INS/Kantar Health La Roche-Posay Barometers 2013